Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026
GlobeNewswire, Inc.
– In the largest long-term hypertension trial of an aldosterone synthase inhibitor to date, lorundrostat demonstrated sustained reduction in automated office systolic blood pressure (AOSBP) of 17.8 mmHg at Week 48 from Launch-HTN baseline – – 56%...
JiKe: China Leading Light Medical Aesthetics Supplier Advancing Anti-Aging Science
EIN Presswire
GUANGZHOU, GUANGDONG, CHINA, November 7, 2026 /EINPresswire.com/ -- What does it truly take for modern skincare formulations to bridge the gap between clinical efficacy and everyday home routines?
Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026
GlobeNewswire, Inc.
HRS/BHB-1893 demonstrated meaningful improvements in exercise capacity and patient-reported outcomes, with rapid, deep, and durable left ventricular outflow tract (LVOT) gradient reduction at 52 weeks Data support a highly simplified dosing...
Science 37 Named 2026 “BioTechnology Innovation of the Year” for its Direct-to-Patient Clinical Trial Delivery Model
GlobeNewswire, Inc.
MORRISVILLE, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Science 37, a nationwide direct-to-patient clinical research site, today announced it has been named “BioTechnology Innovation of the Year” in the 2026 BioTech Breakthrough Awards.
HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer
GlobeNewswire, Inc.
Designated as one of the Top 150 abstracts submitted for the 41st Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class, second-generation, tetravalent pembrolizumab (Keytruda®) based immune checkpoint inhibitor,...
PumasAI Unveils Pumas 2.9 with Advanced Scientific Modeling & Simulation for Clinical Pharmacology and Pharmacometrics
EIN Presswire
Latest release delivers expanded modeling capabilities, improved computational performance, and greater reproducibility for advanced pharmacometric workflows DOVER, DE, UNITED STATES, November 6, 2026 /EINPresswire.com/ -- PumasAI, an AI-powered...
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings
GlobeNewswire, Inc.
WATERTOWN, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that...
Groundbreaking therapy for advanced heart failure: Repairon’s Scientific Co-Founder, Prof. Wolfram-Hubertus Zimmermann, Receives the 2026 “Galenus-von-Pergamon” Award for Outstanding Basic Pharmacological Research
GlobeNewswire, Inc.
GÖTTINGEN, Germany and PROVIDENCE, R.I., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Professor Zimmermann and his research team are recognized for the development of iPSC-derived engineered heart muscle, Repairon’s BioVAT lead product, for the treatment of...
ARO Year in Review 2025 honors 75 years of shaping scientific discovery
DVIDS - Georgia
RESEARCH TRIANGLE PARK, N.C. – The Army Research Office released “ARO Year in Review Fiscal Year 2025,” commemorating 75 years of creating, directing and protecting scientific discovery for the Army and highlighting fiscal 2025 extramural research...
Osteal Therapeutics Announces Three Scientific Presentations Related to the APEX Clinical Trial Program at the 2026 AAHKS Annual Meeting
GlobeNewswire, Inc.
DALLAS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc. (“Osteal”), a clinical-stage biopharmaceutical company developing innovative combination drug/device therapies for orthopedic infections, today announced that three scientific...
Stand Up for Science to Announce Its Accountability Agenda at Tonight’s Election Debrief Rally
EIN Presswire
Virtual event will celebrate democracy and explore next steps for continued civic engagement and SUFS strategies WASHINGTON, DC, UNITED STATES, November 5, 2026 /EINPresswire.com/ -- The midterm election results have flipped both the Senate and...
Novastra Therapeutics Establishes Scientific Advisory Board and Appoints Senior Advisors and Head of Clinical Development
GlobeNewswire, Inc.
Experts in immuno-oncology, medical oncology, clinical development, and regulatory affairs to guide and support advancement of OmniAntigen™ Platform (OAP) programs OAP enables systematic immune reprogramming therapy (XIRT™), designed to overcome...
Learn primitive skills, join a birding citizen science project and more at MDC’s Burr Oak Woods Nature Center in November
Missouri Department of Conservation
We protect and manage the fish, forest, and wildlife of the state.
Robot Fish Are Mining the Ocean. No, This Isn’t Science Fiction.
GlobeNewswire, Inc.
Washington, D.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- The miners of the future may not carry pickaxes.
From Scientific Discovery to Coexistence: Ya'an Offers a Comprehensive Model for Giant Panda Conservation
GlobeNewswire, Inc.
Ya'an Municipal People's Government YA'AN, China, Nov. 05, 2026 (GLOBE NEWSWIRE) -- The Dialogue on Science-based Conservation and Cultural Exchange for Giant Pandas and Golden Snub-Nosed Monkeys opened on November 4 in Ya'an, Sichuan Province,...
Scientists Probe Zeptoverse at Unprecedented Subatomic Scale
MENAFN
(MENAFN) Scientists have detected particle interactions at an unprecedented scale, reaching a realm approximately 100 billion times smaller than an atom, which some physicists refer to as the zeptoverse.
Gain Therapeutics Announces Late-Breakers and Poster Presentations at Upcoming Scientific Conferences
GlobeNewswire, Inc.
BETHESDA, Md., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule...
Stand Up for Science Reacts to Midterm Election Results, Turns Its Focus Towards Accountability
EIN Presswire
WASHINGTON, DC, UNITED STATES, November 4, 2026 /EINPresswire.com/ -- In response to yesterday’s midterm elections, in which voters overwhelmingly chose pro-democracy, pro-science, pro-public health candidates, Stand Up for Science Founder and...
Peer-Reviewed Scientific Journal Publishes U.S. Clinical Study Reporting Interim Results of 87.7% Accuracy for IR-MED’s PressureSafe™ Technology in Pressure-Injury Assessment
GlobeNewswire, Inc.
ROSH PINNA, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Peer-reviewed study published in the HCA Healthcare Journal of Medicine reports Phase 2 interim results of 90.0% sensitivity, 87.3% specificity and an AUC-ROC of 0.959 using a post hoc balanced...
Thea Energy Collaborates with MIT’s Plasma Science and Fusion Center on Planar Coil Magnet Program
GlobeNewswire, Inc.
KEARNY, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Thea Energy, Inc., a fusion power company advancing the stellarator for the commercialization of an abundant source of baseload energy, today announced a collaboration with the Massachusetts...
Sign up for:
Science Times Observer
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.